Activity value 72china Supplier,Last transaction date:
2025-12-27Address: ltd unit 03 g 8th floorblock d xiamen internationalshipping center no 97 xiangyu
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for xiamen myreida pharmaceuticals co from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 9 transactions, with a transaction quantity of 7278.46 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024239444.041230
202597278.460
Bill of lading data
<
1/15
>
Trade date
2025/12/27
B/L No.
7726377
Suppliers
xiamen myreida pharmaceuticals co
Buyers
protech telelinks pvt ltd.
POLs
——
PODs
delhi
Supply area
China
Purchas area
India
Weight
——
Amount
50000
Hs code
29349990
Product tags
raw material,ulinastatin
Product description
ULINASTATIN INTERMEDIATE RAW MATERIAL ULINASTATIN INTERMEDIATE RAW MATERIAL
Expand
Trade date
2025/12/09
B/L No.
8100065
Suppliers
xiamen myreida pharmaceuticals co
Buyers
sanzyme ltd.
xiamen myreida pharmaceuticals co is china Supplier,
and primarily engages in the import and export business of products such as bat,powder,ulinastatin.
According to the 52wmb.com global trade database, as of 2025-12-27, the company has completed 69 international trades,
with its main trading regions covering india,united states etc.
The core products include HS29371900,HS29349990,HS29419090 etc,
often transported via shanghai,port xiamen, port busan etc,
and its main trading partners are samarth life sciences pvt ltd.,darmerica llc,sanzyme ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on xiamen myreida pharmaceuticals co is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.